Microbix Biosystems Inc
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry. Its infectious disease antigens also used in controls for diagnostic assays, basic and applied research in virology, microbiology, cell biology, immunology, and pathology, or for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. In addition, it develops Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of particles that could be used to enrich cell populations of interest, such as in sexing semen. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. Show More...
-
Website http://microbix.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.34 CAD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-09 2011-09 2012-09 2013-09 2014-09 2015-09 2016-09 2017-09 2018-09 2019-09 TTM Earnings Per Share CAD -0.05 -0.05 -0.04 0.010 -0.04 -0.09 -0.010 Dividends CAD Payout Ratio % * Shares Mil 49.0 55.0 62.0 67.0 72.0 82.0 85.0 85.0 96.0 97.0 102.0 Book Value Per Share * CAD 0.11 0.09 0.08 0.06 0.1 0.16 0.17 0.19 0.19 0.11 0.11 Free Cash Flow Per Share * CAD -0.04 -0.02 -0.02 -0.02 -0.03 -0.07 -0.010 -0.02 Return on Assets % -17.88 -18.59 -19.3 0.010 1.1 2.96 3.07 -14.63 -37.69 0.16 -5.1 Financial Leverage (Average) 2.53 2.68 3.28 2.22 1.83 1.72 1.65 1.74 1.87 1.86 1.73 Return on Equity % -42.1 -48.43 -56.88 0.03 2.17 5.22 5.17 -24.81 -67.55 0.31 -9.23 Return on Invested Capital % -16.07 -14.4 -14.21 4.58 5.99 6.33 5.77 -13.09 -39.78 4.75 -0.22 Interest Coverage -1.86 -1.68 -1.49 1.24 1.55 1.47 1.21 -3.58 -9.12 1.04 -0.04 Current Ratio 1.26 1.28 1.17 1.79 1.78 1.4 1.08 0.95 1.46 1.35 1.86 Quick Ratio 0.79 0.68 0.65 1.01 1.07 0.47 0.42 0.24 0.35 0.39 0.57 Debt/Equity 0.99 1.11 1.53 0.89 0.52 0.42 0.31 0.31 0.46 0.41 0.41